Please use this identifier to cite or link to this item:

Full metadata record
DC FieldValueLanguage
dc.contributor.authorGonçalves, Anabela Ferreirapor
dc.contributor.authorda Costa, Andrépor
dc.contributor.authorCasal, Margaridapor
dc.contributor.authorGomes, Andreia Cpor
dc.contributor.authorMachado, Raulpor
dc.description.abstractLeukemia inhibitory factor (LIF) and Oncostatin-M (OSM) are two pleiotropic cytokines from the IL-6 cytokine family with implications in health and disease. Their biotechnological exploitation finds applications in the treatment of different diseases such as cardiac and neurological pathologies, and even cancer. In recent years, several patents and research papers were published regarding their heterologous expression, however problems with production yield, protein stability and activity can significantly hinder the applicability of these cytokines. In this work, we developed a molecular biology platform for the cloning of cytokines LIF or OSM with different recombinant protein-based polymers aiming at their production and subsequent processing into functional materials. As polymers, we used a variant of an elastin-like recombinamer (ELR) and another from silk elastin-like proteins (SELPs). A combination of ELR-intein proteins was used as production, purification and cleavage tag for the cytokines, which can be encapsulated into organic and inorganic particles. On the other hand, a SELP-6xGlycine module was devised to facilitate further processing into a variety of different materials including films, fibres and scaffolds. In this system, we cloned both murine and human forms of the cytokines, to allow their use in different studies and models. Heterologous protein expression studies, using Escherichia coli as cell factory, indicate that all the designed proteins are overexpressed although at different levels depending on the nature of the cytokine, though always suitable for lab-scale utilization. We believe that the modular system here discussed will endow us with sufficient plasticity to design materials adjusted to the pathologies where LIF and OSM are implicated and may have a positive therapeutic impact.por
dc.description.sponsorshipThis work was supported by national funds through the FCT I.P. and by the ERDF through the COMPETE2020 - programa operacional competitividade e internacionalização (POCI) with the strategic program UID/BIA/04050/2019 (POCI-01-0145-FEDER-007569). We also acknowledge support from FCT I.P. within the project FUN2CYT with reference POCI-01-0145-FEDER-030568. Anabela Gonçalves holds a FCT scholarship, reference SFRH/BD/146807/2019.por
dc.subjectLeukemia inhibitory factorpor
dc.subjectOncostatin Mpor
dc.subjectElastin-like recombinamerpor
dc.subjectSilk elastin-like proteinspor
dc.titleA molecular biology platform for the production of cytokines and cytokine-functionalized materialspor
oaire.citationConferenceDate05 Dez. - 07 Dez. 2019por
oaire.citationConferencePlaceCoimbra, Portugalpor
dc.subject.fosCiências Médicas::Biotecnologia Médicapor
Appears in Collections:DBio - Comunicações/Communications in Congresses

Files in This Item:
File Description SizeFormat 
poster Anabela.pdf410,25 kBAdobe PDFView/Open

This item is licensed under a Creative Commons License Creative Commons

Partilhe no FacebookPartilhe no TwitterPartilhe no DeliciousPartilhe no LinkedInPartilhe no DiggAdicionar ao Google BookmarksPartilhe no MySpacePartilhe no Orkut
Exporte no formato BibTex mendeley Exporte no formato Endnote Adicione ao seu ORCID